6505--Etodolac Capsules & Tablets
Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79724R0018
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA) National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79724R0018 for an unrestrictive procurement of Etodolac Capsules and Tablets for the VA, Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract period will be for one year with four one-year option periods, and the items will be distributed through the VA's Pharmaceutical Prime Vendor Programs. Offerors must provide the exact name and NDC number for the drug they will supply. The solicitation will be electronically issued in commercial item format in accordance with FAR Part 12, with a tentative closing date of June 13, 2024. The NAICS code for this procurement is 325412, and interested offerors should monitor sam.gov for any changes and direct questions to the Contracting Officer, Chris Carthron.
This procurement is not set-aside and does not have any incumbent contractors identified. The estimated annual requirements include Etodolac 200mg and 300mg capsules, as well as Etodolac 400mg and 500mg tablets, some of which are for sustained-release formulations. The groups can be awarded separately or to a single vendor, and all responsible sources may submit an offer for consideration.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79724R0018 for an unrestrictive procurement for Etodolac Capsules and Tablets, for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). *Groups can be awarded separately or to a single vendor to the responsible offeror(s) who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79724R0018 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 30, 2024, with a tentative closing date of June 13, 2024. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to: Christopher.Carthron@va.gov.
The estimated annual requirements are as follows:
Item Description Size Estimated Annual Requirements
(Bottles)
Group I
ETODOLAC 200MG CAP 100 8,125
ETODOLAC 300MG CAP 100 14,590
Group II
1 ETODOLAC 400MG TAB 100 42,911
2 ETODOLAC 500MG TAB 100 8,020
Group III
1 ETODOLAC 400MG TAB, SA 100 839
2 ETODOLAC 500MG TAB, SA 100 283
*Groups I, II and Group II do not have to be awarded to the same vendor.
Files
| File | Type | Posted |
|---|---|---|
| 36E79724R0018_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Etodolac Capsules & Tablets | Award Notice | |
| 6505--Etodolac Capsules & Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| Lidocaine 5% patches-request for information | Veterans Integrated Service Network 15 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity